Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
NOVOLOG 70/30 is prescribed to treat high blood sugar in patients who have diabetes. NOVOLOG 70/30 is an insulin product that contains a mixture of insulin Aspart and insulin Aspart protamine.
People with diabetes cannot naturally lower their blood sugar, and high blood sugar damages small blood vessels and can cause permanent organ damage. Insulin products help return high blood sugar to normal by mimicking the insulin that the body naturally produces.
Inject NOVOLOG insulin 70/30 under the skin as directed by the prescriber. The dose of insulin must be individualized for each person. Diet, physical activity, medications, and current blood sugar are all factors that determine a persons dose.
NOVOLOG Mix 70/30 should be cloudy and white in appearance. If the vial is clear or contains particulates, do not use it.
Resuspend NOVOLOG 70/30 before use. It is easiest to resuspend it at room temperature. Once opened, a vial or pen can be used for 28 days and then discarded.
NOVOLOG 70/30 contains rapid-acting insulin and intermediate-acting insulin.
Insulin Aspart is rapid-acting and begins working in about 15 minutes. Thiry percent of NOVOLOG 70/30 is this type of insulin.
Insulin Aspart Protamine is intermediate-acting and provides baseline insulin between meals. Seventy percent of NOVOLOG 70/30 is this type of insulin.
The following medications can affect how your insulin dose:
Always check the insulin label before using it to avoid medication errors.
Do not share NOVOLOG 70/30 pens with multiple patients, even if the pen needle is changed each time.
Hypoglycemia can be life-threatening, so it is important to learn the signs before starting insulin therapy.
The most common side effects of NOVOLOG 70/30 may include:
Novolog 70/30 [package insert] Plainsboro, NJ: Novo Nordisk; 2019.